Trexquant Investment’s BioNTech BNTX Stock Holding History

Trexquant Investment’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,641	Closed	-$244K	–	1533
2024 Q1	$244K	Buy	+2,641	New	+$253K	﹤0.01%	1334
2023 Q2	–	Sell	-58,105	Closed	-$7.24M	–	1460
2023 Q1	$7.24M	Buy	58,105 +28,915	+99%	+$3.97M	0.2%	125
2022 Q4	$4.38M	Buy	+29,190	New	+$4.49M	0.12%	212
2022 Q3	–	Sell	-81,630	Closed	-$12.2M	–	1380
2022 Q2	$12.2M	Buy	+81,630	New	+$12.5M	0.55%	24
2022 Q1	–	Sell	-19,330	Closed	-$4.98M	–	1371
2021 Q4	$4.98M	Buy	+19,330	New	+$5.29M	0.31%	63
2021 Q3	–	Sell	-1,368	Closed	-$306K	–	1144
2021 Q2	$306K	Buy	+1,368	New	+$258K	0.03%	696
2021 Q1	–	Sell	-25,198	Closed	-$2.05M	–	1130
2020 Q4	$2.05M	Buy	25,198 +6,933	+38%	+$681K	0.22%	121
2020 Q3	$1.26M	Buy	+18,265	New	+$1.31M	0.08%	337

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Trexquant Investment's BNTX Position: Q2 2024 in Review

Trexquant Investment sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 2,641 shares — an estimated $244K sold.

Trexquant Investment first reported a position in BNTX in Q3 2020 and held it in 8 quarters. The position peaked at $12.2M in Q2 2022. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

Trexquant Investment reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
Trexquant Investment sold 2,641 BioNTech shares in Q2 2024, an estimated $244K.
Trexquant Investment first reported a position in BioNTech in Q3 2020 and held it in 8 quarters.
Trexquant Investment's BioNTech position peaked at $12.2M in Q2 2022.
286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.